Clarivate

Among the six coronavirus vaccine candidates that have entered human trials, two belong to publicly listed U.S. companies: Moderna Inc (NASDAQ: MRNA) and Inovio Pharmaceuticals Inc (NASDAQ: INO). Both stocks have rallied in reaction to updates on R&D and funding. Moderna is up...